Creating a medication tailored to the needs of an individual patient. FDA answers the “what” and “why” of compounding. From consumers to health care professionals, there are many questions about compounding. FDA works to answer questions related to the meaning, intent and requirements of compounding
Similar Posts
ZoomMax may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use ZoomMax, a product promoted and sold for sexual enhancement on various websites, including www.amazon.com, and possibly in some retail stores.FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy
The U.S. Food and Drug Administration today initiated the process for a label change for acetaminophen (Tylenol and similar products) to reflect evidence suggesting that the use of acetaminophen by pregnant women may be associated with an increased risk of neurological conditions such as autism andLiquid Bicarbonate Concentrate Recall: Nipro Removes MedicaLyte Liquid Bicarbonate Concentrate due to Contamination
Nipro recalls bicarbonate dialysate concentrate due to contamination. Learn about potential serious injuries, fatality risks and essential steps for healthcare providers and patients for this Class I recall.Generic Drugs Program Monthly and Quarterly Activities Report
Monthly and quarterly metrics of the FDA Generic Drugs Program.Green Lumber Holding, LLC Issues Consumer Alert on Counterfeit Products Following FDA Findings
Costa Mesa, California August 28, 2025 – Green Lumber Holding, LLC (“Green Lumber”) is alerting consumers that counterfeit products misrepresented as genuine Green Lumber have been identified and may pose health risks.Efficacy Supplement Approvals
Efficacy Supplement Approvals